Company intelligence / Profile preview
FHER
Guadalajara, Jalisco, Mexicofheritale.eu ↗
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
FHER was a major Mexican pharmaceutical company specializing in the manufacture and commercialization of generic drugs and over-the-counter medications. It was one of Mexico's largest pharma companies until its acquisition by Pfizer in 2003. After the acquisition, its operations were integrated into Pfizer's Latin American business.
- Therapeutic areas
- OtherNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Historically partnered with local distributors and international pharma for licensing prior to Pfizer acquisitionNow part of Pfizer’s global network
Beyond the preview
Go deeper on FHER.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FHER.